Growth Metrics

AC Immune (ACIU) FCF Margin (2015 - 2025)

AC Immune (ACIU) reported FCF Margin of 4918.05% for Q4 2025, down 544786.0% year-over-year from N/an in Q4 2024, and down 147.99% on a QoQ basis from 1983.17% in Q3 2025.

AC Immune (ACIU) has 9 years of FCF Margin data on file, last reported at 4918.05% in Q4 2025.

  • Quarterly FCF Margin fell 544786.0% year-over-year to 4918.05% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 1372.9% (down 152777.0% YoY) and the FY2025 annual result came in at 1961.1%, down 220431.0% from the prior year.
  • FCF Margin slipped to 4918.05% in Q4 2025 per ACIU's latest filing, from 1983.17% in the prior quarter.
  • Across five years, FCF Margin topped out at 10639.74% in Q2 2024 and bottomed at 4918.05% in Q4 2025.
  • The 3-year median for FCF Margin is 778.01% (2025), against an average of 92.34%.
  • Peak annual rise in FCF Margin reached 192834 bps in 2025, while the deepest fall reached 1185176 bps in 2025.
  • Tracing ACIU's FCF Margin over 3 years: stood at 344.0% in 2022, then surged by 254 bps to 529.82% in 2024, then sank by 1028 bps to 4918.05% in 2025.
  • Per Business Quant, the three latest ACIU FCF Margin figures stand at 4918.05% (Q4 2025), 1983.17% (Q3 2025), and 1212.02% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 AC Immune 325.88 Mn 211.53 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -4,918.05%
Sep 30, 2025 -1,983.17%
Jun 30, 2025 -1,212.02%
Mar 31, 2025 -1,918.79%
Dec 31, 2024 529.82%
Sep 30, 2024 -54.83%
Jun 30, 2024 10,639.74%
Sep 30, 2022 -344.00%
Dec 31, 2020 -2,291.95%
Sep 30, 2020 -1,366.61%
Jun 30, 2020 -1,338.41%
Mar 31, 2020 -77.15%
Dec 31, 2019 -1,109.88%
Sep 30, 2019 752.64%
Jun 30, 2019 -1,085.11%
Mar 31, 2019 88.61%
Dec 31, 2018 -1,332.11%
Sep 30, 2018 -507.68%
Jun 30, 2018 -331.56%
Mar 31, 2018 -841.63%
Dec 31, 2017 190,242.34%
Sep 30, 2017 -2,663,861.20%
Jun 30, 2017 -1,012.00%
Mar 31, 2017 -562.91%
Dec 31, 2016 -562.55%
Sep 30, 2016 682.08%
Jun 30, 2016 4.14%
Mar 31, 2016 -1,534.91%
Dec 31, 2015 -912.35%